Mitchell Eichhorn, MD
Surgery of the Hand · Waco, TXNPI 1649566613
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.5%), education and other — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Arthrex at 49.5% of the total. Reporting peaked in 2022 at $1,705 and has fallen 87.9% since, to $207 in 2025.
Across 40 payments — averaging $68.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- Integra Lifesciences Corporation$761
- Pylant Medical$142
- Alafair Biosciences, Inc.$138
- Stryker$76
- Axogen$70
- plus $188 from 6 others
What the payments were for
- Food & beverage$1,37651%
- Education$1,20044%
- Other$1475%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 8 | $1,348 |
| Integra Lifesciences Corporation | 15 | $761 |
| Pylant Medical | 2 | $142 |
| Alafair Biosciences, Inc. | 2 | $138 |
| Stryker | 2 | $76 |
| Axogen | 3 | $70 |
| Mentor Worldwide LLC | 3 | $64 |
| Solventum Corporation | 1 | $35 |
| Johnson & Johnson | 1 | $32 |
| Bioventus LLC | 1 | $22 |
| Sonex Health, Inc. | 1 | $19 |
| Averitas Pharma Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,723 in reported general payments places this provider in the 55th percentile of 68 surgery of the hand providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 232 | $1,578 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 153 | $770 |
| Doxycycline Hyclate | 46 | $431 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $110 |
| Tramadol Hcl | 16 | $52 |
Paid to pharmacies, not to this prescriber.
Other surgery of the hand in Waco
- Desirae McKeeLubbock$59K
- Stuart HilliardDenton$21K
- Harrison KayAustin$19K
- Suresh KoneruSan Antonio$17K
- Dustin RayDallas$15K
- Laurence WeiderDallas$13K
- Andrew ZhangDallas$11K
- James HovisArlington$11K
- James LinSpring$10K
- Michael JonesSan Antonio$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.